How do you distinguish between senile/hypertensive sigmoid septal hypertrophy versus sigmoid septal hypertrophy seen in hypertrophic cardiomyopathy?

Ask a clinical question

Answers grounded in the literature and physician expertise.

Related Questions

How are you incorporating the newer RCT data suggesting no mortality benefit to indefinite beta-blocker therapy for patients who are several years out from an MI with preserved LVEF and no angina or arrhythmia?

Is there a role for GLP-1 receptor agonists to reduce thirst in patients with ESRD or CHF who struggle with fluid restriction?

Has the FRAIL-AF trial, which found that switching frail older patients with atrial fibrillation from warfarin to a DOAC was associated with more bleeding rather than less, changed how you approach this transition in your most frail patients successfully treated with warfarin?

About Mednet

A community where doctors find answers to medicine's toughest questions.

Verified, credentialed physicians
45,000+ members across 23 specialties
Free CME and MOC credit

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
Mobile App

Company

About
Careers
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.